- ISIN
- US0727303028
- CUSIP
- 072730302
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
Highlights
- Market Cap
- $38.83B
- Enterprise Value
- $80.23B
- EPS (TTM)
- -$0.53
- Total Revenue (TTM)
- $45.36B
- Gross Profit (TTM)
- $26.91B
- EBITDA (TTM)
- $7.30B
- Year Range
- $7.19 - $14.85
- ROA (TTM)
- -1.92%
- ROE (TTM)
- -7.18%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BAYRY Performance Chart
Bayer AG PK (BAYRY) is down 8.4% since the beginning of the year. At $10 per share, BAYRY is trading 33.5% below its 52-week high of $15. Investors who bought $1,000 worth of BAYRY shares 5 years ago would now be looking at an investment worth $676.
Loading charts...
Returns By Period
Bayer AG PK (BAYRY) has returned -8.42% so far this year and 36.87% over the past 12 months. Over the last ten years, BAYRY has returned -6.56% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.
Bayer AG PK
- 1D
- -2.66%
- 1M
- -11.07%
- YTD
- -8.42%
- 6M
- 0.91%
- 1Y
- 36.87%
- 3Y*
- -10.81%
- 5Y*
- -7.53%
- 10Y*
- -6.56%
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
BAYRY Monthly Returns History
Based on dividend-adjusted daily data since Sep 27, 2007, BAYRY's average daily return is +0.02%, while the average monthly return is +0.32%. At this rate, an investment would double in approximately 18.1 years.
Historically, 47% of months were positive and 53% were negative. The best month was Apr 2011 with a return of +39.7%, while the worst month was Oct 2008 at -32.2%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 5 months.
On a daily basis, BAYRY closed higher 45% of trading days. The best single day was Apr 6, 2011 with a return of +24.6%, while the worst single day was Oct 27, 2008 at -42.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 21.53% | -6.46% | -6.67% | -2.41% | -5.55% | -6.35% | -8.42% | ||||||
| 2025 | 15.57% | 5.14% | 1.52% | 9.99% | 7.28% | 6.65% | 2.65% | 6.20% | 0.85% | -6.51% | 13.61% | 22.88% | 122.78% |
| 2024 | -15.17% | -3.07% | 0.92% | -4.32% | 5.75% | -8.81% | 5.97% | 3.49% | 9.72% | -20.07% | -24.22% | -4.87% | -46.92% |
| 2023 | 21.15% | -4.56% | 7.13% | 2.57% | -11.01% | -1.14% | 5.64% | -6.10% | -12.47% | -10.42% | -20.74% | 8.33% | -25.35% |
| 2022 | 13.65% | -3.98% | 18.31% | -4.29% | 12.53% | -16.55% | -2.35% | -9.09% | -12.42% | 13.67% | 10.81% | -11.68% | 0.35% |
| 2021 | 2.47% | 0.61% | 3.79% | 5.72% | -0.99% | -4.93% | -2.53% | -6.77% | -1.81% | 4.26% | -11.00% | 5.07% | -7.34% |
Benchmark Metrics
Bayer AG PK has an annualized alpha of -3.40%, beta of 0.76, and R2 of 0.21 versus S&P 500 Index. Calculated based on daily prices since September 28, 2007.
- This stock participated in 117.11% of S&P 500 Index downside but only 74.81% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.21 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -3.40%
- Beta
- 0.76
- R²
- 0.21
- Upside Capture
- 74.81%
- Downside Capture
- 117.11%
Return for Risk
Risk / Return Rank
BAYRY ranks 66 for risk / return — better than 66% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Bayer AG PK (BAYRY) and compare them to S&P 500 Index.
| BAYRY | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.94 | 2.39 | -1.45 |
Sortino ratioReturn per unit of downside risk | 1.57 | 3.25 | -1.68 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.43 | -0.24 |
Calmar ratioReturn relative to maximum drawdown | 1.19 | 3.11 | -1.93 |
Martin ratioReturn relative to average drawdown | 2.94 | 14.38 | -11.44 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Bayer AG PK provided a 0.32% dividend yield over the last twelve months, with an annual payout of $0.03 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.03 | $0.03 | $0.03 | $0.63 | $0.55 | $0.59 | $0.54 | $0.55 | $1.00 | $1.31 | $0.69 | $0.63 |
Dividend yield | 0.32% | 0.29% | 0.60% | 6.85% | 4.27% | 4.48% | 3.61% | 2.71% | 5.69% | 4.20% | 2.65% | 2.03% |
Monthly Dividends
The table displays the monthly dividend distributions for Bayer AG PK. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.63 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.63 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.55 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.59 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.59 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Bayer AG PK. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Bayer AG PK was 83.33%, occurring on Dec 26, 2024. The portfolio has not yet recovered.
The current Bayer AG PK drawdown is 65.79%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -83.33%Dec 2024 | 9y 9mo | — | 11y 2moMar 2015 - now |
Financial crisis2007–2009 | -55.34%Mar 2009 | 1y 2mo | 3y 6mo | 4y 8moJan 2008 - Sep 2012 |
2015 correction2015 | -13.38%Jan 2015 | 1mo 4d | 2mo 10d | 3mo 14dDec 2014 - Mar 2015 |
2014 correction2014 | -11.88%Oct 2014 | 4mo 14d | 1mo 7d | 5mo 21dJun 2014 - Nov 2014 |
2014 correction2014 | -11.11%Apr 2014 | 3mo 15d | 16d | 4mo 1dDec 2013 - May 2014 |
Drawdown Indicators
| BAYRY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.33% | -56.78% | -26.55% |
Max Drawdown (1Y)Largest decline over 1 year | -31.19% | -9.10% | -22.09% |
Max Drawdown (3Y)Largest decline over 3 years | -66.65% | -18.90% | -47.75% |
Max Drawdown (5Y)Largest decline over 5 years | -71.71% | -25.43% | -46.28% |
Max Drawdown (10Y)Largest decline over 10 years | -83.02% | -33.92% | -49.10% |
Current DrawdownCurrent decline from peak | -65.79% | 0.00% | -65.79% |
Average DrawdownAverage peak-to-trough decline | -34.31% | -10.72% | -23.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.56% | 1.97% | +10.59% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Bayer AG PK over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Bayer AG PK is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BAYRY relative to other companies in the Drug Manufacturers - General industry. Currently, BAYRY has a P/S ratio of 0.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BAYRY in comparison with other companies in the Drug Manufacturers - General industry. Currently, BAYRY has a P/B value of 1.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with BAYRY
Add Bayer AG PK to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BAYRY